Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

Brazil

 

FREE BLOG Middle income countries and elderly care

Orpea’s acquisition of MEDI-System, the largest nursing home chain in Poland, shows the huge potential for private elderly care in middle income countries in Europe and around the world.

UnitedHealth Group wades further into Brazilian mess

The US insurer, UnitedHealth Group (UHG), has bought Hospital Samaritano of Brazil through its local subsidiary, Amil Participacoes. The local press puts the deal at $350m. UHG now owns 32 hospitals in the troubled market. Analysts say UHG forecasts Amil’s sales to fall next year, but margins are better for operators.

Report: All listed healthcare service companies active in Emerging Markets

Here we present the first comprehensive list of all 57 quoted healthcare service companies which are active in Emerging Markets. The list includes companies headquartered in the Developed World, who have interests in Emerging Markets, such as Air Liquide, Fresenius or Ramsay Health Care, as well as quoted operators from the region, such as IHH, Apollo or Integrated Diagnostic Holdings. It covers everyone from Chilean hospitals to Egyptian lab operators and from NYSE quoted operators in China to big groups in Malaysia and Indonesia.

Senior Assist to triple beds in Chile

Senior Assist, the Belgian elderly care group, expects its nursing home business in Chile to triple to 1,500 beds by 2018. The group has also opened homes in Turkey and Uruguay and is looking at Colombia, Russia and Thailand. We talk to Roderick Peters, CEO of Senior Assist Latin America about the Latin America market.

Advent buys 13% of Fleury

Private equity group Advent International has purchased a minority stake in quoted Brazilian diagnostics provider Grupo Fleury for an undisclosed fee. An inside source tells us there is no drag along. We also spoke to chairman Dr Marcos Bosi Ferraz about the deal and the impact of the recession on the private healthcare industry.

Interview: Dr Mark Kurtser, chairman, MD Medical Group

Shares in MDMG, the largest Russian player in obs, gynae and paediatrics have crashed 70% since its listing on the London Stock Exchange in 2012, yet there doesn’t seem a lot wrong with the half year results with sales up 36% at RUB 4.52bn ($70m) and EBITDA ahead 29% at RUB 1.25bn ($20m) in the first half of 2015. Kurtser, once chief obstetrician and gynaecologist of the city of Moscow and the go-to-doctor for the Russian elite, has built the business from scratch and still owns 68%.

FREE BLOG Falling currency spells doom for some

You’re running a hospital group in an emerging market and your medtech bill suddenly doubles, so does your rent and your debt. That is the reality for many Russian hospital groups after the currency halved against the dollar. Western medtech is vital and dollar-denominated debt and rents are common.

Interview: Dr Mark Kurtser, chairman, MD Medical Group

Shares in MDMG, the largest Russian player in obs, gynae and paediatrics have crashed 70% since its listing on the London Stock Exchange in 2012, yet there doesn’t seem a lot wrong with the half year results with sales up 36% at RUB 4.52bn ($70m) and EBITDA ahead 29% at RUB 1.25bn ($20m) in the first half of 2015. Kurtser, once chief obstetrician and gynaecologist of the city of Moscow and the go-to-doctor for the Russian elite, has built the business from scratch and still owns 68%.

FREE BLOG Luddism, outcome measures and healthcare

Luddism comes in many forms. Even a well versed and articulate argument put forward by medical professionals to stop people filling in a survey. You might say an analogy between modern-day brain surgeons and Victorian textile workers, is pushing it, but the results are the same. Social and economic progress is stymied by a narrow interest group resisting technological or procedural change, and that is precisely what the resistance to tranparency and performance measurement in healthcare represents.

Find Us